UBS AM’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-48,885
| Closed | -$3.19M | – | 2810 |
|
|
2018
Q1 | $3.19M | Buy |
48,885
+47,515
| +3,468% | +$3.1M | ﹤0.01% | 1288 |
|
|
2017
Q4 | $100K | Hold |
1,370
| – | – | ﹤0.01% | 2400 |
|
|
2017
Q3 | $126K | Hold |
1,370
| – | – | ﹤0.01% | 2341 |
|
|
2017
Q2 | $90.6K | Hold |
1,370
| – | – | ﹤0.01% | 2349 |
|
|
2017
Q1 | $297K | Buy |
+1,370
| New | +$297K | ﹤0.01% | 2018 |
|
|
2016
Q4 | – | Sell |
-1,203
| Closed | -$163K | – | 2688 |
|
|
2016
Q3 | $163K | Hold |
1,203
| – | – | ﹤0.01% | 2508 |
|
|
2016
Q2 | $122K | Sell |
1,203
-22,223
| -95% | -$2.25M | ﹤0.01% | 2563 |
|
|
2016
Q1 | $3.84M | Sell |
23,426
-88
| -0.4% | -$14.4K | ﹤0.01% | 1108 |
|
|
2015
Q4 | $7.7M | Hold |
23,514
| – | – | 0.01% | 928 |
|
|
2015
Q3 | $7.59M | Buy |
23,514
+88
| +0.4% | +$28.4K | 0.01% | 937 |
|
|
2015
Q2 | $9.33M | Buy |
23,426
+22,456
| +2,315% | +$8.95M | 0.01% | 911 |
|
|
2015
Q1 | $478K | Buy |
970
+33
| +4% | +$16.3K | ﹤0.01% | 1995 |
|
|
2014
Q4 | $335K | Buy |
+937
| New | +$335K | ﹤0.01% | 2156 |
|
|
2014
Q2 | – | Sell |
-28,538
| Closed | -$7.29M | – | 2591 |
|
|
2014
Q1 | $7.29M | Buy |
28,538
+3,144
| +12% | +$804K | 0.01% | 943 |
|
|
2013
Q4 | $5.03M | Buy |
+25,394
| New | +$5.03M | 0.01% | 1009 |
|